Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets

Joen Rong Sheu, Cheng Rong Lee, Chien Huang Lin, George Hsiao, Wun-Chang Ko, Yao Chang Chen, Mao Hsiung Yen

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose-dependently (0.1-1.0 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LTA also dose-dependently inhibited phosphoinositide breakdown and intracellular Ca+2 mobilization in human platelets stimulated by collagen. LTA (0.5 and 1.0 μg/ml) also significantly inhibited thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LTA (0.1-1.0 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. Rapid phosphorylation of a platelet protein of Mr. 47,000 (P47), a marker of protein kinase C activation, was triggered by PDBu (30 nM). This phosphorylation was markedly inhibited by LTA (0.5 and 1.0 μg/ml) within a 10-min incubation period. These results indicate that the antiplatelet activity of LTA may be involved in the following pathways: LTA's effects may initially be due to induction of conformational changes in the platelet membrane, leading to a change in the activity of phospholipase C, and subsequent inhibition of phosphoinositide breakdown and thromboxane A2 formation, thereby leading to inhibition of both intracellular Ca+2 mobilization and phosphorylation of P47 protein. Therefore, LTA-mediated alteration of platelet function may contribute to bleeding diathesis in Gram-positive septicemic and endotoxemic patients.

Original languageEnglish
Pages (from-to)777-784
Number of pages8
JournalThrombosis and Haemostasis
Volume83
Issue number5
Publication statusPublished - 2000

Fingerprint

Staphylococcus aureus
Blood Platelets
Thromboxane A2
Phosphorylation
Phosphatidylinositols
Collagen
Membranes
Disease Susceptibility
Type C Phospholipases
lipoteichoic acid
Platelet Aggregation
Protein Kinase C
Proteins
Fluorescence
Hemorrhage

Keywords

  • Gram-positive bacteria
  • Lipoteichoic acid
  • Membrane fluidity
  • Platelet aggregation
  • Protein kinase C

ASJC Scopus subject areas

  • Hematology

Cite this

Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets. / Sheu, Joen Rong; Lee, Cheng Rong; Lin, Chien Huang; Hsiao, George; Ko, Wun-Chang; Chen, Yao Chang; Yen, Mao Hsiung.

In: Thrombosis and Haemostasis, Vol. 83, No. 5, 2000, p. 777-784.

Research output: Contribution to journalArticle

@article{4c1371648d7a4b29b4f2c70c9b506bfb,
title = "Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets",
abstract = "In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose-dependently (0.1-1.0 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LTA also dose-dependently inhibited phosphoinositide breakdown and intracellular Ca+2 mobilization in human platelets stimulated by collagen. LTA (0.5 and 1.0 μg/ml) also significantly inhibited thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LTA (0.1-1.0 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. Rapid phosphorylation of a platelet protein of Mr. 47,000 (P47), a marker of protein kinase C activation, was triggered by PDBu (30 nM). This phosphorylation was markedly inhibited by LTA (0.5 and 1.0 μg/ml) within a 10-min incubation period. These results indicate that the antiplatelet activity of LTA may be involved in the following pathways: LTA's effects may initially be due to induction of conformational changes in the platelet membrane, leading to a change in the activity of phospholipase C, and subsequent inhibition of phosphoinositide breakdown and thromboxane A2 formation, thereby leading to inhibition of both intracellular Ca+2 mobilization and phosphorylation of P47 protein. Therefore, LTA-mediated alteration of platelet function may contribute to bleeding diathesis in Gram-positive septicemic and endotoxemic patients.",
keywords = "Gram-positive bacteria, Lipoteichoic acid, Membrane fluidity, Platelet aggregation, Protein kinase C",
author = "Sheu, {Joen Rong} and Lee, {Cheng Rong} and Lin, {Chien Huang} and George Hsiao and Wun-Chang Ko and Chen, {Yao Chang} and Yen, {Mao Hsiung}",
year = "2000",
language = "English",
volume = "83",
pages = "777--784",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "5",

}

TY - JOUR

T1 - Mechanisms involved in the antiplatelet activity of Staphylococcus aureus lipoteichoic acid in human platelets

AU - Sheu, Joen Rong

AU - Lee, Cheng Rong

AU - Lin, Chien Huang

AU - Hsiao, George

AU - Ko, Wun-Chang

AU - Chen, Yao Chang

AU - Yen, Mao Hsiung

PY - 2000

Y1 - 2000

N2 - In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose-dependently (0.1-1.0 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LTA also dose-dependently inhibited phosphoinositide breakdown and intracellular Ca+2 mobilization in human platelets stimulated by collagen. LTA (0.5 and 1.0 μg/ml) also significantly inhibited thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LTA (0.1-1.0 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. Rapid phosphorylation of a platelet protein of Mr. 47,000 (P47), a marker of protein kinase C activation, was triggered by PDBu (30 nM). This phosphorylation was markedly inhibited by LTA (0.5 and 1.0 μg/ml) within a 10-min incubation period. These results indicate that the antiplatelet activity of LTA may be involved in the following pathways: LTA's effects may initially be due to induction of conformational changes in the platelet membrane, leading to a change in the activity of phospholipase C, and subsequent inhibition of phosphoinositide breakdown and thromboxane A2 formation, thereby leading to inhibition of both intracellular Ca+2 mobilization and phosphorylation of P47 protein. Therefore, LTA-mediated alteration of platelet function may contribute to bleeding diathesis in Gram-positive septicemic and endotoxemic patients.

AB - In this study, Gram-positive Staphylococcus aureus lipoteichoic acid (LTA) dose-dependently (0.1-1.0 μg/ml) and time-dependently (10-60 min) inhibited platelet aggregation in human platelets stimulated by agonists. LTA also dose-dependently inhibited phosphoinositide breakdown and intracellular Ca+2 mobilization in human platelets stimulated by collagen. LTA (0.5 and 1.0 μg/ml) also significantly inhibited thromboxane A2 formation stimulated by collagen in human platelets. Moreover, LTA (0.1-1.0 μg/ml) dose-dependently decreased the fluorescence of platelet membranes tagged with diphenylhexatrience. Rapid phosphorylation of a platelet protein of Mr. 47,000 (P47), a marker of protein kinase C activation, was triggered by PDBu (30 nM). This phosphorylation was markedly inhibited by LTA (0.5 and 1.0 μg/ml) within a 10-min incubation period. These results indicate that the antiplatelet activity of LTA may be involved in the following pathways: LTA's effects may initially be due to induction of conformational changes in the platelet membrane, leading to a change in the activity of phospholipase C, and subsequent inhibition of phosphoinositide breakdown and thromboxane A2 formation, thereby leading to inhibition of both intracellular Ca+2 mobilization and phosphorylation of P47 protein. Therefore, LTA-mediated alteration of platelet function may contribute to bleeding diathesis in Gram-positive septicemic and endotoxemic patients.

KW - Gram-positive bacteria

KW - Lipoteichoic acid

KW - Membrane fluidity

KW - Platelet aggregation

KW - Protein kinase C

UR - http://www.scopus.com/inward/record.url?scp=0034018372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034018372&partnerID=8YFLogxK

M3 - Article

C2 - 10823277

AN - SCOPUS:0034018372

VL - 83

SP - 777

EP - 784

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 5

ER -